Caplin Point Laboratories Limited
NSE: CAPLIPOINT
Employs 4,199 permanent employees and workers, 5.9% on the year before, as filed for the year to 31 Mar 2026 on a group basis. Revenue in the quarter to 31 Dec 2024 was ₹185 cr.
Headcount
Annual, from the BRSR filed with NSE (as of 31 March each year)
| As of | Scope | Permanent | Change (%) | Contract / other | Change (%) |
|---|---|---|---|---|---|
| 31 Mar 2023 | Group | 1,642 | — | 244 | — |
| 31 Mar 2024 | Group⚠ | 3,406 | 1,764(107.4%) | 1,476 | 1,232(504.9%) |
| 31 Mar 2025 | Group | 3,966 | 560(16.4%) | 1,566 | 90(6.1%) |
| 31 Mar 2026 | Group | 4,199 | 233(5.9%) | 1,256 | −310(19.8%) |
- ⚠Unusually large change — often a change in what the company counts.
Permanent = permanent employees + permanent workers, as defined in SEBI's BRSR. "Standalone" figures cover the listed company alone and exclude its subsidiaries.
Financials (₹ cr)
| Period | Revenue (₹ cr) | Change (%) | Employee cost (₹ cr) | Change (%) | Net profit (₹ cr) | Change (%) | Flags |
|---|---|---|---|---|---|---|---|
| Quarter ended 31 Dec 2024 | 185 | −23(11.1%) | 14 | 1(7.7%) | 75 | −31(29.3%) | |
| Quarter ended 30 Sept 2024 | 208 | 22(11.8%) | 13 | 2(18.2%) | 106 | 33(45.2%) | |
| Quarter ended 30 Jun 2024 | 186 | 47(33.8%) | 11 | 1(10.0%) | 73 | 3(4.3%) | |
| Quarter ended 31 Mar 2024 | 139 | 6(4.5%) | 10 | 0(0.0%) | 70 | 15(27.3%) | |
| Quarter ended 31 Dec 2023 | 133 | −46(25.7%) | 10 | 1(11.1%) | 55 | −27(32.9%) | |
| Quarter ended 30 Sept 2023 | 179 | 5(2.9%) | 9 | −1(10.0%) | 82 | 6(7.9%) | |
| Quarter ended 30 Jun 2023 | 174 | 29(20.0%) | 10 | −1(9.1%) | 76 | 22(40.7%) | |
| Quarter ended 31 Mar 2023 | 145 | 14(10.7%) | 11 | 2(22.2%) | 54 | −5(8.5%) | |
| Quarter ended 31 Dec 2022 | 131 | 19(17.0%) | 9 | 1(12.5%) | 59 | 30(103.5%) | |
| Quarter ended 31 Mar 2022 | 112 | −16(12.5%) | 8 | 0(0.0%) | 29 | −10(25.6%) | ⚠ |
| Quarter ended 31 Dec 2021 | 128 | −32(20.0%) | 8 | 1(14.3%) | 39 | −26(40.0%) | ⚠ |
| Quarter ended 30 Sept 2021 | 160 | 32(25.0%) | 7 | 0(0.0%) | 65 | 10(18.2%) | ⚠ |
| Quarter ended 30 Jun 2021 | 128 | 5(4.1%) | 7 | 0(0.0%) | 55 | 24(77.4%) | ⚠ |
| Quarter ended 31 Mar 2021 | 123 | −17(12.0%) | 7 | −5(40.1%) | 31 | −6(15.9%) | ⚠ |
| Quarter ended 31 Dec 2018 | 140 | 9(6.5%) | 12 | 0(3.5%) | 37 | 7(24.4%) | ⚠ |
| Quarter ended 30 Sept 2018 | 131 | 21(18.8%) | 11 | 1(15.0%) | 30 | 8(37.3%) | ⚠ |
| Quarter ended 31 Mar 2018 | 110 | — | 10 | — | 22 | — | ⚠ |